1558 related articles for article (PubMed ID: 32492406)
21. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19.
Ren H; Yang Y; Wang F; Yan Y; Shi X; Dong K; Yu X; Zhang S
Cardiovasc Diabetol; 2020 May; 19(1):58. PubMed ID: 32393351
[TBL] [Abstract][Full Text] [Related]
22. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
[TBL] [Abstract][Full Text] [Related]
23. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
24. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
Kanberg N; Ashton NJ; Andersson LM; Yilmaz A; Lindh M; Nilsson S; Price RW; Blennow K; Zetterberg H; Gisslén M
Neurology; 2020 Sep; 95(12):e1754-e1759. PubMed ID: 32546655
[TBL] [Abstract][Full Text] [Related]
25. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
Gao Y; Li T; Han M; Li X; Wu D; Xu Y; Zhu Y; Liu Y; Wang X; Wang L
J Med Virol; 2020 Jul; 92(7):791-796. PubMed ID: 32181911
[TBL] [Abstract][Full Text] [Related]
28. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
[TBL] [Abstract][Full Text] [Related]
29. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
Yip CYC; Yap ES; De Mel S; Teo WZY; Lee CT; Kan S; Lee MCC; Loh WNH; Lim EL; Lee SY
Br J Haematol; 2020 Jul; 190(1):33-36. PubMed ID: 32420610
[No Abstract] [Full Text] [Related]
30. Researchers Home in on COVID-19 Severity Biomarkers.
Abbasi J
JAMA; 2020 Jul; 324(2):128. PubMed ID: 32662846
[No Abstract] [Full Text] [Related]
31. The Diagnostic Value of Multi-Index Combined Detection in Patients with COVID-19.
Liang Y; Wang Q; Zhao Y; Niu X; Chen Y; Chen X; Wang Y; Zhou X; Xu Z; Wu S
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180449
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
33. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis.
Lapić I; Rogić D; Plebani M
Clin Chem Lab Med; 2020 Jun; 58(7):1146-1148. PubMed ID: 32386190
[No Abstract] [Full Text] [Related]
34. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
35. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
Elgedawy GA; Samir M; Elabd NS; Elsaid HH; Enar M; Salem RH; Montaser BA; AboShabaan HS; Seddik RM; El-Askaeri SM; Omar MM; Helal ML
PLoS One; 2024; 19(5):e0302977. PubMed ID: 38814977
[TBL] [Abstract][Full Text] [Related]
36. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India.
Gupta N; Ish P; Kumar R; Dev N; Yadav SR; Malhotra N; Agrawal S; Gaind R; Sachdeva H; Covid Working Group OMOTSH
Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33169598
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China.
Cao Z; Li T; Liang L; Wang H; Wei F; Meng S; Cai M; Zhang Y; Xu H; Zhang J; Jin R
PLoS One; 2020; 15(6):e0234764. PubMed ID: 32555674
[TBL] [Abstract][Full Text] [Related]
39. Temporal changes in computed tomography of COVID-19 pneumonia with perilobular fibrosis.
Ng FH; Li SK; Lee YC; Ma JKF
Hong Kong Med J; 2020 Jun; 26(3):250.e1-251.e2. PubMed ID: 32362587
[No Abstract] [Full Text] [Related]
40. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
Mahmud I; Garrett TJ
J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
